drugset / Trial / NCT01381731
A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of this trial are to: * Assess the safety and tolerability of diquafosol tetrasodium ophthalmic solution versus placebo following one week of treatment in subjects undergoing photorefractive keratectomy (PRK). * Evaluate the potential of diquafosol to accelerate corneal wound healing/re-epithelialization following PRK.
Timeline
- Start
- 2005-04
- Primary completion
- 2005-06
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diquafosol | Oligonucleotide (other) | 2 % | Topical |
Indications
No indication recorded.